Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for Cryo-Cell International Inc. (CCEL : AMEX)

• Company Description    CRYO-CELL International is engaged in cryogenic cellular storage and the design and developmentof cellular storage devices. They currently focus on the processing and preservation of umbilical cord blood stem cells for autologous/sibling use. They have pioneered several technologies that allow for the processing and storage of specimens in a cryogenic environment, and presently, their mission of affordability for U-Cord blood preservation remains in effect. Number of Employees: 76

• Price / Volume Information    Yesterday's Closing Price: $3.45 Daily Weekly Monthly 20 Day Moving Average: 10,896 shares Shares Outstanding: 8.06 (millions) Market Capitalization: $27.82 (millions) Beta: 0.49 52 Week High: $6.35 52 Week Low: $2.72 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week -0.48% -8.31% 12 Week 0.76% -6.90% Year To Date 0.39% -7.12%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 700 Brooker Creek Blvd. Suite 1800 - Oldsmar,FL 34677 USA ph: 813-749-2100 fax: 813-855-4745 investors@cryo-cell.com http://www.cryo-cell.com

• General Corporate Information    Officers David Portnoy - Chairman and Co-Chief Executive Officer Jill Taymans - Chief Financial Officer Harold Berger - Director Daniel Mizrahi - Director Mark Portnoy - Director Peer Information Cryo-Cell International Inc. (CHCR) Cryo-Cell International Inc. (ESRX) Cryo-Cell International Inc. (MYDP) Cryo-Cell International Inc. (COR) Cryo-Cell International Inc. (GBCS) Cryo-Cell International Inc. (LAXAF) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: Medical Services Sector: Medical CUSIP: 228895108 SIC: 8090 Fiscal Year Fiscal Year End: November Last Reported Quarter: 02/01/26 Next Expected EPS Date: 07/21/26 Share - Related Items Shares Outstanding: 8.06 Most Recent Split Date: (:1) Beta: 0.49 Market Capitalization: $27.82 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $ Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $ Payout Ratio: Number of Estimates in the Fiscal Year Consensus: Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: 07/21/26

• Fundamental Ratios P/E Current FY Estimate: - Trailing 12 Months: - PEG Ratio: - Price Ratios Price/Book: - Price/Cash Flow: - Price / Sales: 0.89 EPS Growth vs. Year Ago Period: -66.67% vs. Previous Quarter: 102.13% Sales Growth vs. Year Ago Period: -3.59% vs. Previous Quarter: -2.04% ROE 02/28/26 - - 11/30/25 - - 08/31/25 - - ROA 02/28/26 - -4.26 11/30/25 - -3.83 08/31/25 - -0.74 Current Ratio 02/28/26 - 0.62 11/30/25 - 0.59 08/31/25 - 0.63 Quick Ratio 02/28/26 - 0.60 11/30/25 - 0.57 08/31/25 - 0.60 Operating Margin 02/28/26 - -8.52 11/30/25 - -7.70 08/31/25 - -1.49 Net Margin 02/28/26 - -8.52 11/30/25 - -7.70 08/31/25 - -1.49 Pre-Tax Margin 02/28/26 - -8.95 11/30/25 - -7.40 08/31/25 - 4.57 Book Value 02/28/26 - -2.28 11/30/25 - -2.31 08/31/25 - -1.84 Inventory Turnover 02/28/26 - 13.44 11/30/25 - 11.94 08/31/25 - 10.84 Debt-to-Equity 02/28/26 - - 11/30/25 - - 08/31/25 - - Debt-to-Capital 02/28/26 - - 11/30/25 - - 08/31/25 - -

Powered by Zacks Investment Research ©